SEARCH

SEARCH BY CITATION

Keywords:

  • Corpus luteum;
  • lymphocytes and luteal function;
  • resident leukocytes

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

Citation Pate JL, Toyokawa K, Walusimbi S, Brzezicka E. The interface of the immune and reproductive systems in the ovary: lessons learned from the corpus luteum of domestic animal models. Am J Reprod Immunol 2010

The dynamic changes that characterize the female reproductive system are regulated by hormones. However, local cell-to-cell interactions may mediate responsiveness of tissues to hormonal signals. The corpus luteum (CL) is an excellent model for understanding how immune cells are recruited into tissues and the role played by those cells in regulating tissue homeostasis or demise. Leukocytes are recruited into the CL throughout its lifespan, and leukocyte-derived cytokines have been found in corpora lutea of all species examined. The proinflammatory cytokines inhibit gonadotropin-stimulated steroidogenesis, profoundly stimulate prostaglandin synthesis by luteal cells, and promote apoptosis. However, there is mounting evidence that leukocytes and luteal cells communicate in different ways to maintain homeostasis within the functional CL. Domestic animals have provided important information regarding the presence and role of immune cells in the CL.


Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

The discipline of reproductive immunology emerged from studies of the phenomenon by which the fetal allograft is tolerated by the maternal immune system, and it brought together researchers trained in basic reproductive physiology with those trained as immunologists in the more classical sense. Surely, the paradox of the fetal allograft remains at the forefront of reproductive immunology research and while great discoveries have been made, the mechanisms by which the fetus escapes rejection by the mother continue to engage the curiosity of reproductive immunologists. Meanwhile, a much broader field of reproductive immunology has emerged and includes studies of physiological processes in all reproductive tissues, as well as pathological conditions that impact fertility, autoimmunity, sexually transmitted diseases and reproductive cancers. The function of reproductive tissues may be modified by circulating immune cells and the cytokines they produce, but a feature common to most reproductive tissues is the presence of resident immune cells that may also be integrally involved in the regulation of tissue functions, including those of the gonads.

The corpus luteum (CL) is an ephemeral tissue, and its hormonal regulation is well characterized. The dynamic nature of luteal development, function and regression, coupled with the ability to precisely manipulate these processes, makes the CL an excellent model for understanding how immune cells are recruited into tissues and the role played by those cells in regulating tissue homeostasis or demise. The CL of domestic ruminants shares common features with the human CL. Both are derived from ovulation of a single, dominant follicle and develop into a fully functional CL in every cycle. The lifespan of the CL is very similar in humans and ruminants, allowing for ready comparisons to be made along the timeline of development, maintenance and regression. In contrast, rodents ovulate multiple follicles and the CL that are formed do not reach a plateau of function, but regress almost immediately after differentiation. Studies of the CL using rodent models employ hormones or physical manipulation to induce pseudopregnancy. However, the corpora lutea of pseudopregnant rodents secrete estrogen, similar to the human CL, whereas little to no estrogen is secreted from ruminant CL. This emphasizes the importance of choosing an appropriate animal model to answer a particular question. The differences that exist in luteal function among all the species also underscore the need to obtain basic information about gonadal function using diverse animal models. This review will be presented in the context of how domestic animals have been used to provide insight into the presence and role of leukocytes in luteal function and will review the more recent literature regarding immune cells in the ovary. For more comprehensive reviews, the reader is referred to previous reviews by the lead author1–4 as well as those of other well-known scholars in the field.5–7

Leukocytes in follicular development, ovulation and luteinization

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

Bukovsky and Presl8 proposed a role for the immune system in ovarian function and in 1980, Espey9 hypothesized that ovulation of ovarian follicles involves an inflammatory reaction. Evidence has since accumulated that supports these hypotheses, as well as indicating a potential role for immune cells and/or cytokines in the processes of follicular development, ovulation and luteinization. Cyclic variation in follicular chemokine expression implies that the ovary directs the recruitment of leukocytes to the follicle.10 Microarray analyses of bovine follicles indicated that immune response genes, including genes for chemokines and cytokines, were differentially expressed in follicles of different sizes, suggesting a role for these molecules in follicular development.11,12 Rats treated with granulocyte macrophage colony-stimulating factor (CSF2) had a greater number of large, pre-antral follicles compared to control rats.13 During the pre-ovulatory phase in women, monocyte chemoattractant protein (CCL2) is upregulated in the stroma surrounding the follicle, and macrophages are recruited during the ovulatory process.14 T lymphocytes are also recruited to the pre-ovulatory follicle. An interesting observation made using mice was that rare CD8αα+ T cells migrate into the pre-ovulatory follicle in response to the chemokine, thymus-expressed chemokine (TECK), and those cells are necessary for ovulation.15 Interleukin (IL) 8 induces neutrophil accumulation during ovulation in the rabbit16 and in the rat, human chorionic gonadotropin (hCG) induces an increase in the chemokine, fractalkine (CX3CL1), which enhances gonadotropin-stimulated progesterone production in cultured follicles and granulosal cells.17

Because of the ready availability of granulosal cells and follicular fluid from follicles of women undergoing IVF procedures, the presence of immune cells and cytokines in follicles can be measured and correlated with pregnancy outcome in humans. Macrophage colony-stimulating factor (CSF1) and its receptor are expressed in, and increase steroidogenesis by, human granulosal cells.18,19 Granulosal cells also produce the chemokine CXCL12 and express its receptor, CXCR4.20 These authors demonstrated that CXCL12 could induce migration of CD3+ T cells, but not B cells or natural killer cells, and suggested that recruitment of T cells to the follicle was associated with decreased apoptosis of granulosal cells. Women with endometriosis have reduced pregnancy rates following IVF compared to those with tubal infertility. The reduced fertility may be partially owing to the immune response mechanisms in the follicle, because concentrations of regulated upon activation, normal T cell expressed and secreted (RANTES) and CCL2 were altered in follicular fluid of women with endometriosis.21 Cytotoxic peptides, such as defensins, have been detected in human follicular fluid, but there was no correlation between defensin concentration and fertility in those patients.22 Pregnancy outcomes after IVF were greater in women who had fewer NKT (CD56+ CD3+) cells and more immunoregulatory NK (CD56+ CD16) cells.23 In summary, data collected using multiple species – rodents, rabbits, cows and humans – collectively point to an important role for leukocytes in follicular development and ovulation; however, domestic animal models have been less well studied in regard to the involvement of the immune system in follicular development.

Inflammation includes increased capillary permeability, leading to accumulation of fluid. It could be that the inflammatory process that characterizes ovulation results in leaking of leukocytes, such as macrophages, eosinophils and neutrophils into the surrounding tissue. This could be a non-specific accumulation that is rapidly cleared, or they could have a role in resolving the inflammatory process, which would be critical to ensure proper development of the CL. Cellular FLICE-like inhibitory protein (cFLIP), an antiapoptotic protein, is present in macrophages, steroidogenic and endothelial cells in greatest concentrations in the developing CL and may confer protective effects against apoptosis to ensure survival of the tissue despite high numbers of macrophages and granulocytes in the tissue.24 In CSF2-deficient mice, there is increased activation of ovarian macrophages, which coincides with compromised luteinization and steroidogenesis in early pregnancy.25 There is also evidence that leukocytes are involved in the process of luteinization. It has also been suggested that eosinophils influence the process of angiogenesis during luteal development.26,27 The chemokine responsible for the selective migration of eosinophils may be Substance P, because it is produced in the developing CL, along with its receptor, neurokinin-1 receptor.28 Although eotaxin was proposed to play this role, Vogel et al. (2005)29 detected only very minimal amounts of eotaxin mRNA in the bovine ovary.

Identification of immune cell types in the CL

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

Immune cells are present in the CL of all species studied thus far. Many studies have focused on the increase in immune cells observed during luteolysis, but immune cells are present in the CL throughout its lifespan. Immunohistochemical analyses reve-aled that the type of leukocytes changes with functional state of the CL. In the bovine CL, there appears to be an inverse relationship in the number of granulocytes and lymphocytes throughout the lifespan of the CL. Eosinophils are more abundant in developing than fully functional CL30,31 and appear to be recruited into the developing CL by expression of P-selectin (CD62P) on endothelial cells.32 In contrast, T lymphocytes are undetectable or exist in very low number in the developing CL, but the number of T cells is greater in a fully functional CL and further increases during luteolysis.33,34 T lymphocytes are generally categorized into the major classes of CD4+, CD8+ or γδ+ cells. Temporal changes in each of these classes of T cells might lead to suggestions about their roles in luteal function. However, use of immunohistochemical techniques to quantify these cells in bovine luteal tissue sections has led to discrepant results. Bauer et al. (2001)33 and Townson et al. (2002)34 observed greater numbers of both CD4+ and CD8+ cells in regressing CL, suggesting a role for both cell types in luteolysis. However, Penny et al. (1999)30 observed no change in the number of CD4+ T cells. Further, Bauer et al. (2001)33 reported that CD8+ cells were found in proportionally greater number than CD4+ cells, whereas Townson et al. (2002)34 found no significant difference in the proportion of CD4+ and CD8+ cells. Davis and Pate (2007)35 reported the presence of γδ+ T cells in midcycle and regressing CL, but quantitative analysis was not performed in that study. In an effort to better understand changes in T-lymphocyte populations in the bovine CL, we recently undertook a study to isolate resident T cells from the CL and characterize them via flow cytometry. More CD8+ than CD4+ T cells were observed in the luteal-resident T-cell population using this method. It was also apparent that specific subpopulations of T cells are selected for migration into the CL, and changes in subsets of the major classes of T cells may be more reflective of their functional significance than overall proportions of CD4+, CD8+ or γδ+ cells.36 Macrophages also increase in the bovine CL during luteal regression.33–35

Although less well studied than the cow, the horse, sheep and pig have also been used to characterize changes in immune cells during the lifespan of the CL. Similar to the cow, T cells were greater in the equine CL late in the estrous cycle and administration of prostaglandin (PG)F resulted in an increase in CD8+ cells.37 Studies using the sheep and pig have shown that eosinophils were greater in the developing CL, but eosinophils38–40 as well as macrophages41 migrate into the CL during luteolysis, and two macrophage phenotypes may be distinguished based on presence or absence of cytoplasmic lipid droplets.42 Neutrophils are present in much lower number than eosinophils. T lymphocytes also increase during luteolysis in mice,43,44 but no changes were observed during pregnancy or pseudopregnancy in rats.45

Rabbits have served as an excellent model to study changes in T cells and macrophages related to luteal function. T cells are found within the CL prior to the recruitment of macrophages,46 but it is the macrophages that increase in number during luteal regression47,48 or following estradiol withdrawal.49 In the rabbit, it seems that T cells infiltrate into the CL first, followed by macrophages.47 However, in the mouse, macrophages decline in number in the latter stages of luteal regression, whereas T lymphocytes continue to increase.43 Macrophages derived from mouse ovaries are less active than circulating macrophages in the uptake of foreign molecules, suggesting that the tissue environment may regulate the function of resident macrophages.50 The recruitment of monocytes/macrophages into the CL of the rat is independent of the concentration of progesterone.50

Although Brannstrom et al.45 did not observe a change in the number of T cells in the human CL during the menstrual cycle, most reports characterizing lymphocytes in human CL indicated that T cells increase in the late luteal phase,51–53 similar to what has been reported for the bovine CL. Also similar to bovine CL, B cells and NK cells are undetectable or in very low number in human CL,51–54 whereas eosinophils and neutrophils are greater in developing CL.27,52,53 Macrophages are present in the human CL, but it is not clear whether they exist in greater number in the early CL,55 or continue to increase to a maximum in the late luteal phase.56 Of note is that fewer macrophages are present in the CL after in vivo treatment with hCG to simulate early pregnancy.56

Recruitment of leukocytes into the CL

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

The dynamic nature of leukocyte populations in the CL suggests that production of chemokines or temporal changes in endothelial cell adhesion molecules must regulate the transmigration of leukocytes into the luteal parenchyma. Surprisingly, a limited amount of work has been performed in this area. In the cow, most of the work on chemokines has focused on CCL2, which appears to play a pivotal role in the recruitment of macrophages and lymphocytes into the CL. The mRNA for CCL2 is greater in regressing compared to functional CL57,58 and CCL2 protein increased with age of the CL; concentration of CCL2 and its mRNA were correlated with accumulation of monocytes, macrophages and T lymphocytes.34,57 The expression of CCL2 on luteal endothelial cells was stimulated by tumor necrosis factor alpha (TNF) and interferon gamma (IFNG).59 Interestingly, CCL2 was upregulated in day 11, but not day 4, CL by injection of PGF, implying a potential role of this chemokine in the acquisition of luteolytic capacity.60

Human granulosal-lutein cells secrete IL8, which could serve as the chemoattractant for the neutrophils that infiltrate the developing CL.61 Although the horse is not as commonly used for studies of ovarian function, Lawler et al. (2002)62 used culture medium collected after incubation of luteal tissue to demonstrate that the equine CL produces chemokines for both mononuclear and polymorphonuclear cells in late diestrus and during luteolysis, but not during the midluteal phase.

Cytokine expression and actions in the CL

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

Tumor necrosis factor-α is produced in the CL and may have a functional role in luteolysis. TNF concentrations were greater in regressing CL and corresponded to the accumulation of macrophages.46,47 Luteal concentration of IL10, which is considered to be an antiinflammatory cytokine, increases at the same time as TNF in rabbit CL,48 leading those authors to speculate that antiinflammatory cytokines are necessary to control immune cell function during luteolysis, a concept that was also proposed by Pate and Keyes (2001).4 Around the same time, work began on expression and function of cytokines in the bovine CL. The mRNA for TNF30,63,64 and IFNG63 are detectable in bovine CL. Although the luteal concentration of TNF mRNA does not vary significantly during the estrous cycle, the protein is greater on estrous cycle days 13–18.64 The ability of TNF to elicit a physiological response in the CL is suggested by the presence of TNF receptor type I (TNFRI). Interestingly, fewer TNFRI receptors were present in the day 15–17 CL, which is the time that corresponds to the greater concentrations of TNF, suggesting that TNF may downregulate its own receptor in this tissue.64 Shaw and Britt65 measured the secretion of luteal TNF using continuous flow in vivo microdialysis. The cytokine was only detectable in the dialysate following the decline in progesterone, indicating that TNF may be secreted from cells into the intercellular spaces to facilitate luteal regression. The first functional effects of TNF on luteal cells were demonstrated using bovine cells, in which TNF increased production of prostaglandins, decreased LH-stimulated progesterone synthesis and upregulated class I, but not class II, major histocompatibility (MHC) molecules,66 as well as a proteosomal subunit responsible for processing of MHC class I-presented peptides, LMP10.67 Although these effects of TNF would be consistent with a role in luteolysis, there is some evidence that higher concentrations of TNF promote luteal survival.68,69

Using cultured bovine luteal cells, it was demonstrated that IFNG has effects similar to those of TNF. Interferonγ inhibits LH-stimulated progesterone production, increases prostaglandin synthesis, upregulates class I and class II MHC molecules and causes cell death.70,71 The apoptotic effects of IFNG on luteal cells involve upregulation of Fas expression72 and are mediated by the action of indoleamine 2,3-dioxygenase, which essentially starves the cells of tryptophan.73 The effects of IFNG on luteal cells are potentiated in the presence of TNF,66,72 probably because of TNF-induced upregulation of IFNG receptors.74 Induction of apoptosis by IFNG + TNF can be suppressed by IFNA or acetylcholine,75,76 and progesterone may confer some protective effect against apoptosis in the CL.77

Additional cytokines that have been detected in the bovine CL include interleukin 1α (IL1A), IL1β (IL1B), transforming growth factor (TGFB1), macrophage migration inhibitory factor (MIF) and osteopontin (SPP1). Both interleukins stimulate prostaglandin production by luteal cells, but have no effect on progesterone synthesis.78,79 Interleukin 6 decreased the progesterone production by porcine luteal cells, and IL6 receptor mRNA was increased in the regressing compared to the functional CL.64 The greatest amount of MIF mRNA was found in the developing CL and MIF was localized to large luteal cells, suggesting a potential role in differentiation of granulosal-luteal cells in addition to its role as a proinflammatory cytokine.80 Another proinflammatory cytokine, SPP1, is present in the bovine CL81 and may play a role in paracrine communication between luteal cells and T cells.82 Bovine luteal cells in vitro secrete large amounts of TGFB1.83 Treatment of luteal cells with TGFB1 reduces progesterone secretion, and the actions of TGFB1 are likely mediated by the activation of the early growth response (EGR)1 protein, which is upregulated during PGF-induced luteolysis.84 Overall, since the late 1980s, the bovine CL has served as a useful model to study cytokines in luteal function, and the data collectively point to a role of the proinflammatory cytokines in luteolysis. However, more work needs to be undertaken to determine functional interactions of the complex array of cytokines found within the CL.

A number of investigators have obtained similar results using rodent and primate CL. Interleukin 1A, IL1B and IL18 were detected in the murine CL,85,86 and IL1B stimulated the prostaglandin production in luteal cells from rats.87 The reports of effects of IL1B on progesterone production have been inconsistent. Interleukin 1B has been reported to suppress progesterone synthesis in CL of rats,87 stimulate progesterone synthesis in human luteal cells88,89 or have no effect in bovine luteal cells.78,79 While it is tempting to speculate that there are species differences in the effects of IL1B on steroidogenesis, it is likely that the differences are a result of the in vitro conditions. In fact, using human luteal cells, Castro et al.90 and Kohen et al.91 demonstrated that completely opposite effects of IL1B on progesterone production could be obtained depending on the presence or absence of luteal leukocytes in the cultures. In those studies, leukocytes appeared to mediate the antisteroidogenic effects of IL1B, because IL1B stimulated steroidogenesis in leukocyte-depleted cultures. In rodents and primates, the expression and functional effects of TNF and IFNG appear to be similar to what has been observed in the cow. No profound changes were noted in concentrations of TNF throughout the lifespan of the murine CL, while IFNG was detected only in regressed CL.43 Similar to what had been observed in bovine luteal cells,66 TNF inhibited progesterone production in luteal cells from rats, and this action was a result of downregulation of steroidogenic acute regulatory protein (StAR) and luteinizing hormone (LH) receptor.43 Also similar to the cow, the combination of TNFA and IFNG exert profound proapoptotic effects on rodent luteal cells92,93 and alter the Fas/FasL system.43,94 In macaque CL, TNF mRNA increases with age of the CL,95 and human luteal cells collected during the late luteal phase secrete greater concentrations of TNF in vitro than cells from the early luteal phase.96 Further, luteolytic effects of TNF and IFNG on human and non-human primate luteal cells also appear to involve Fas/FasL. Using mutant mouse models, Henkes et al.97 provided strong evidence for a role of TNF, mediated by increased activity of acid sphingomyelinase, in luteolysis. Thus far, similar types of single-gene mutant domestic animal models have not been developed, providing one limitation in studying pathways that mediate cytokine action in these species.

Role of immune cells in luteolysis

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

The expression and functional effects of the proinflammatory cytokines described above point to a role in luteolysis. The mRNA of the three most well-studied cytokines in regard to luteal function, IL1B, TNF and IFNG, are upregulated during luteolysis in the cow,98 as is TNF receptor I.99 It is likely that multiple cell types are targets for the actions of TNF in the regressing CL. As previously stated, TNF, either alone or in combination with IFNG, inhibits LH-stimulated progesterone production while stimulating prostaglandin production by steroidogenic cells. Conversely, the apoptotic effects of TNF may be exerted primarily on luteal endothelial cells because TNF-induced apoptosis in cultures of luteal endothelial, but not steroidogenic, cells.99 TNF-induced upregulation of chemokine secretion by endothelial cells100 may be an early signal to recruit leukocytes into the CL to facilitate luteolysis. In fact, despite being the known luteolytic agent in ruminants, PGF does not upregulate CCL2 secretion by cultured luteal endothelial cells nor does it mediate the onset of apoptosis in luteal steroidogenic or endothelial cells.3,101 However, chemokine secretion by luteal endothelial cells is stimulated by coculture with peripheral blood leukocytes (PBLs), which are presumably doing so via secretion of cytokines such as TNF.10,101 These authors clearly demonstrate that complex interrelationships among immune cells, endothelial cells and steroidogenic cells are necessary for PGF-induced luteal regression.

In all species studied, there are greater numbers of macrophages and lymphocytes in the regressing CL than in the functional CL. This is primarily because of the transmigration of leukocytes from the capillaries into the parenchymal tissue. However, the percentage of proliferating leukocytes increases from 20% in a fully functional CL to 70% during luteal regression.33 Most of the proliferating cells are macrophages, although proliferation of a small proportion of lymphocytes was also observed in that study. This raises the very interesting question of not only what factors recruit leukocytes into the CL, but what causes the resident leukocytes to be activated and proliferate when the CL undergoes regression.

It has been suggested that one activator of luteal monocytes is prokineticin 1, which is found in greater abundance in the regressing than functional CL.102 T lymphocytes may also be activated by altered expression of, or peptide presentation by, MHC molecules. Class I MHC molecules are constitutively expressed on all luteal cells, whereas expression of class II MHC molecules is restricted to subpopulations of luteal cells and is increased late in the estrous cycle and during luteolysis.67 However, expression of MHC molecules, costimulatory molecules, and the intracellular components of the peptide processing machinery for presentation by MHC are all present long before luteolysis and T-cell activation occurs.67,103,104 In fact, the mRNA for the CD80 and CD86 costimulatory molecules and DMα, which is a component of the MHC class II antigen processing machinery, are found in greater concentrations in midcycle compared to late cycle CL.103,104 Interestingly, the IFNG-inducible proteosomal subunit, LMP10, is upregulated in luteal cells by TNF, whereas DMα is downregulated.103 Also, class II MHC expression on luteal cells is reduced in vivo during maternal recognition of pregnancy105 and in vitro by combined treatment with progesterone and IFNA.2

Immune cells and homeostasis within the CL

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

Bovine luteal cells are potent stimulators of T-cell proliferation in vitro.106 Luteal cells collected from regressing CL, which possess a greater number of class II MHC molecules are more potent stimulators of T-cell proliferation than midcycle luteal cells, and luteal cell-induced T-cell proliferation is inhibited by high concentrations of progesterone.67,107 Blocking costimulatory molecule function with antibodies results in a reduction in luteal cell-induced T-cell proliferation.104 Collectively, all these results point to a role for MHC molecules in the activation of T cells within the CL during luteolysis. However, a number of more recent observations have led to an expanded hypothesis about the interactions between luteal cells and lymphocytes in the CL. First, the addition of anti-MHC blocking antibodies to luteal cell–T cell cocultures only partially suppresses T-cell proliferation.35,106 Secondly, the majority of the MHC molecules were localized to subsets of capillary endothelial cells in situ, with similar expression in CL collected on day 10 and day 18 of the estrous cycle.104 Cytokeratin-negative bovine luteal endothelial cells express class II MHC molecules in culture,100 whereas cultured luteal steroidogenic cells express only minimal class II MHC in the absence of IFNG.70 Finally, we discovered that the T cells that are most responsive to luteal cells are γδ+ T cells, which are not MHC restricted.35 The responses of γδ T cells tend to be driven more by imbalance within the host tissue, requiring γδ T-cell autoreactivities to be tightly controlled.107 Most information on tissue-specific γδ T cells has been obtained from studies of these cells localized within skin and gut epithelium (known as intraepithelial lymphocytes, or IELs), but a distinct subset of γδ T cells comprise about one-half of all T cells within reproductive epithelia108,109 and are thought to be important for non-rejection of the fetal allograft. In fact, γδ T cells within the reproductive tract are increased nearly 100-fold in pregnant animals compared to non-pregnant animals,110 and more γδ T cells are found in the peripheral blood of healthy pregnant women compared to that of non-pregnant women or recurrent aborters.111

Although the stimulation of T cells by luteal cells may lead to activation of a proinflammatory response during luteolysis, it is equally plausible that luteal cells and resident immune cells interact in such a way as to regulate homeostasis within the tissue during periods of tissue remodeling and/or extremely high metabolic activity. The interaction of multiple cell types, including immune cells, to maintain homeostasis within the ovary was proposed by Bukovsky et al.112 and was termed the ‘tissue control system’. A role for immune cells to abate an inflammatory response in the ovary was postulated by Pate and Keyes.4

Conclusion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References

In summary, leukocytes are recruited into the CL throughout its lifespan, but the specific types of leukocytes found within luteal tissue vary depending on the functional state of the CL. Cytokines that are produced primarily by lymphocytes and macrophages have been found in corpora lutea of all species examined and have profound effects on luteal cells in vitro. Interactions between leukocytes and luteal parenchymal cells (steroidogenic and endothelial cells) result in functional changes in both the parenchymal cells and the leukocytes, suggesting that bidirectional communication is an important component in overall regulation of tissue function and is likely as important in homeostasis as in regression of the CL. A summary of the proposed interactions between ovarian parenchymal cells and leukocytes is depicted in Fig. 1. The ephemeral nature of the CL and the ability to hormonally control its development and demise make it a relevant tissue in which to study dynamic changes in tissue resident leukocytes. Although it is critical that diverse species be studied to develop a comprehensive picture of the role of leukocytes in luteal function, the size and accessibility of the bovine CL provides an exceptionally useful model for these studies.

image

Figure 1.  (a) Leukocytes and their products participate in the process of ovulation. LH-induced biochemical changes within the thecal layer initiate a series of changes in the basement membrane as well as leakage in the thecal vasculature. Chemokines (CCL2, CXCL12, TECK and CSF2) present in follicular fluid of pre-ovulatory follicles coupled with increased expression of adhesion molecules on endothelial cells facilitate recruitment of specific leukocyte subpopulations. Leukocytes secrete products that facilitate rupture of the follicular wall, tissue remodeling and proliferation of luteal cells after ovulation. (b) Interaction between leukocytes and luteal cells in a functional and regressing corpus luteum (CL). Infiltrating leukocytes in the CL may assume different roles relative to the state of the CL. The activated immune cells expressing ligands to endothelial adhesion molecules are recruited into the CL in response to chemokine mediators IL8 and CCL2, which are produced by endothelial cells. In a functional CL, immune cells may potentiate survival by producing antiapoptotic molecules like cFLIP. During regression, in response to PGF, increased expression of inflammatory cytokines (TNF, IFNG) inhibit P4 production and activate endothelial cells to recruit more immune cells. IL1B, IFNG and TNF may also activate resident T cells with upregulation of FasL. FasL induces apoptosis in Fas-expressing luteal cells. Inflammatory cytokines also induce apoptosis in both luteal cells and endothelial cells. Bidirectional communication between luteal and immune cells may thus facilitate hormonally regulated survival and demise of the CL. Solid lines represent bidirectional communication whereas dashed lines depict secreted molecules. LLC, large luteal cells; SLC, small luteal cells; LEC, luteal endothelial cells; Mac, macrophage/monocyte; IFNG, interferon gamma; TNF, tumor necrosis factor.

Download figure to PowerPoint

References

  1. Top of page
  2. Abstract
  3. Introduction
  4. Leukocytes in follicular development, ovulation and luteinization
  5. Identification of immune cell types in the CL
  6. Recruitment of leukocytes into the CL
  7. Cytokine expression and actions in the CL
  8. Role of immune cells in luteolysis
  9. Immune cells and homeostasis within the CL
  10. Conclusion
  11. Acknowledgments
  12. References
  • 1
    Pate JL: Cellular components involved in luteolysis. J Anim Sci 1994; 72:18841890.
  • 2
    Pate JL: Involvement of immune cells in regulation of ovarian function. J Reprod Fert Suppl 1995; 49:365377.
  • 3
    Pate JL, Townson DT: Novel local regulators in luteal regression. J Anim Sci 1994;72:3142.
  • 4
    Pate JL, Keyes PK: Immune cells in the corpus luteum: friends or foes? Reproduction 2001;122:665676.
  • 5
    Webb R, Woad KJ, Armstrong DG: Corpus luteum (CL) function: local control mechanisms. Domest Anim Endocrinol 2002; 23:277285.
  • 6
    Townson DH, Liptak AR: Chemokines in the corpus luteum: implications of leukocyte chemotaxis. Reprod Biol Endocrinol 2003; 1:94.
  • 7
    Bukovsky A, Caudle MR: Immune physiology of the mammalian ovary – a review. Am J Reprod Immunol 2008; 59:1226.
  • 8
    Bukovsky A, Presl J: Ovarian function and the immune system. Med Hypotheses 1979; 5:415436.
  • 9
    Espey LL: Ovulation as an inflammatory reaction – a hypothesis. Biol Reprod 1980; 22:73106.
  • 10
    Wong KHH, Negishi H, Adashi EY: Expression, hormonal regulation, and cyclic variation of chemokines in the rat ovary: key determinants of the intraovarian residence of representatives of the white blood cell series. Endocrinology 2002; 143:784791.
  • 11
    Skinner MK, Schmidt M, Savenkova ML, Sadler-Riggleman I, Nilsson EE: Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle development. Mol Reprod Dev 2008; 75:14571472.
  • 12
    Liu Z, Youngquist RS, Garverick HA, Antoniou E: Molecular mechanisms regulating bovine ovarian follicular selection. Mol Reprod Dev 2009; 76:351366.
  • 13
    Wang H, Wen Y, Polan ML, Boostanfar R, Feinman M, Behr B: Exogenous granulocyte-macrophage colony-stimulating factor promotes follicular development in the newborn rat in vivo. Hum Reprod 2005; 20:27492756.
  • 14
    Dahm-Kähler P, Ghahremani M, Lind AK, Sundfeldt K, Brännström M: Monocyte chemotactic protein-1 (MCP-1), its receptor, and macrophages in the perifollicular stroma during the human ovulatory process. Fertil Steril 2009; 91:231239.
  • 15
    Zhou C, Wu J, Borillo J, Torres L, McMahon J, Bao Y, Lou YH: Transient expression of cc chemokine TECK in the ovary during ovulation: its potential role in ovulation. Am J Reprod Immunol 2005; 53:238248.
  • 16
    Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Yoshinaga M, Okamura H: Interleukin-8 as an essential factor in the human chorionic gonadotropin-induced rabbit ovulatory process: Interleukin-8 induces neutrophil accumulation and activation in ovulation. Biol Reprod 1998; 58:526530.
  • 17
    Zhao P, De A, Hu Z, Li J, Mulders SM, Gelpke MDS, Duan EK, Hsueh AJW: Gonadotropin stimulation of ovarian fractalkine expression and fractalkine augmentation of progesterone biosynthesis by luteinizing granulosa cells. Endocrinology 2008; 149:27822789.
  • 18
    Salmassi A, Zhang Z, Schmutzler AG, Koch K, Buck S, Jonat W, Mettler L: Expression of mRNA and protein of macrophage colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertil Steril 2005; 83:419425.
  • 19
    Zhang Z, Fang Q, Wang J: Involvement of macrophage colony-stimulating factor (M-CSF) in the function of follicular granulosa cells. Fertil Steril 2008; 90:749754.
  • 20
    Kryczek I, Frydman N, Gaudin F, Krzysiek R, Frachin R, Emilie D, Chouaib S, Zou W, Machelon V: The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality. Am J Reprod Immunol 2005; 54:270283.
  • 21
    Xu H, Schultze-Mosgau A, Agic A, Diedrich K, Taylor RN, Hornung D: Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization. Fertil Steril 2006; 86:16161620.
  • 22
    Das S, Bates MD, Vince GS, Lewis-Jones I, Gazvani R: Follicular fluid expression of alpha-defensins and their role in ovulation. J Assist Reprod Genet 2008; 25:8387.
  • 23
    Křížan J, Cuchalová L, Šíma P, Králíčková M, Madar J, Větvička V: Altered distribution of NK and NKT cells in follicular fluid is associated with IVF outcome. J Reprod Immunol 2009; 82:8488.
  • 24
    Hojo T, Al-Ztabi MO, Komiyama J, Manabe N, Acosta TJ, Okuda K: Expression and localization of cFLIP, an anti-apoptotic factor, in the bovine corpus luteum. J Reprod Dev 2009; [Epub ahead of print].
  • 25
    Jasper MJ, Robertson SA, Van der Hoek KH, Bonello N, Brännström M, Norman RJ: Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol Reprod 2000; 62:704713.
  • 26
    Murdoch WJ, Steadman LE: Investigation concerning the relationship of ovarian eosinophilia to ovulation and luteal function in the sheep. Am J Reprod Immunol 1991; 25:8187.
  • 27
    Aust G, Simchen C, Heider U, Hmeidan FA, Blumenauer V, Spanel-Borowski K: Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures. Mol Hum Reprod 2000; 6:10851091.
  • 28
    Reibiger I, Aust G, Tscheudschilsuren G, Beyer R, Gebhardt C, Spanel-Borowski K: The expression of substance P and its neurokinin-1 receptor mRNA in the bovine corpus luteum of early developmental stage. Neurosci Lett 2001; 299:4952.
  • 29
    Vogel B, Klinder A, Sittig D, Aust G: Bovine eotaxin (CCL11) – an unusual member of the eotaxin group – attracts eosinophils in vitro but is not responsible for eosinophilia in the ovary. Vet Immunol Immunopathol 2005; 107:6777.
  • 30
    Penny LA, Armstrong D, Bramley TA, Webb R, Collins RA, Watson ED: Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. J Reprod Fertil 1999; 115:8796.
  • 31
    Reibiger I, Spanel-Borowski K: Difference in localization of eosinophils and mast cells in the bovine ovary. J Reprod Fertil 2000; 118:243249.
  • 32
    Rohm F, Spanel-Borowski K, Eichler W, Aust G: Correlation between expression of selectins and migration of eosinophils into the bovine ovary during the periovulatory period. Cell Tissue Res 2002; 309:313322.
  • 33
    Bauer M, Reibiger I, Spanel-Borowski K: Leucocyte proliferation in the bovine corpus luteum. Reproduction 2001; 121:297305.
  • 34
    Townson DH, O’Connor CL, Pru JK: Expression of monocyte chemoattractant protein-1 and distribution of immune cell populations in the bovine corpus luteum throughout the estrous cycle. Biol Reprod 2002; 66:361366.
  • 35
    Davis TL, Pate JL: Proliferation of major histocompatibility nonrestricted gamma delta T cells is stimulated by bovine luteal cells. Biol Reprod 2007; 77:914922.
  • 36
    Poole DH, Pate JL: Loss of regulatory T lymphocytes in the regressing corpus luteum. Biol Reprod 2009; 81:abstract no. 87.
  • 37
    Lawler DF, Hopkins J, Watson ED: Immune cell populations in the equine corpus luteum throughout the oestrous cycle and early pregnancy: an immunohistochemical and flow cytometric study. J Reprod Fertil 1999; 117:281290.
  • 38
    Murdoch WJ: Treatment of sheep with prostaglandin F2 alpha enhances production of a luteal chemoattractant for eosinophils. Am J Reprod Immunol Microbiol 1987; 15:5256.
  • 39
    Cavender JL, Murdoch WJ: Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod 1988; 39:989997.
  • 40
    Standaert FE, Zamora CS, Chew BP: Quantitative and qualitative changes in blood leukocytes in the porcine ovary. Am J Reprod Immunol 1991; 25:163168.
  • 41
    Hehnke KE, Christenson LK, Ford SP, Taylor M: Macrophage infiltration into the porcine corpus luteum during prostaglandin F2α-induced luteolysis. Biol Reprod 1994; 50:1015.
  • 42
    Kim WS, Han SR, Son SK, Park CS, Yang YS: A morphological study on the macrophages during luteolysis in the pig. J Anim Sci Technol 2006; 48:191202.
  • 43
    Komatsu K, Manabe N, Kiso M, Shimabe M, Miyamoto H: Changes in localization of immune cells and cytokines in corpora lutea during luteolysis in murine ovaries. J Exp Zool 2003; 296A:152159.
  • 44
    Sander VA, Piehl L, Facorro GB, Rubin de Celis R, Motta AB: Regulation of functional and regressing stages of corpus luteum development in mice. Role of reactive oxygen species. Reprod Fertil Dev 2008; 20:760769.
  • 45
    Brännström M, Giesecke L, Moore IC, Van Den Heuvel CJ, Robertson SA: Leukocyte subpopulations in the rat corpus luteum during pregnancy and pseudopregnancy. Biol Reprod 1994; 50:11611167.
  • 46
    Bagavandoss P, Kunkel SL, Wiggins RC, Keyes PL: Tumor necrosis factor-α (TNF-α) production and localization of macrophages and T lymphocytes in the rabbit corpus luteum. Endocrinology 1988; 122:11851187.
  • 47
    Bagavandoss P, Wiggins RC, Kunkel SL, Remick DG, Keyes PL: Tumor necrosis factor production and accumulation of inflammatory cells in the corpus luteum of pseudopregnancy and pregnancy in rabbits. Biol Reprod 1990; 42:367376.
  • 48
    Krusche CA, Vloet TD: Functional and structural regression of the rabbit corpus luteum is associated with altered luteal immune cell phenotypes and cytokine expression patterns. Histochem Cell Biol 2002; 118:479489.
  • 49
    Naftalin DM, Bove SE, Keyes PL, Townson DH: Estrogen withdrawal induces macrophage invasion in the rabbit corpus luteum. Biol Reprod 1997; 56:11751180.
  • 50
    Itoh M, Yano A, Li X, Miyamoto K, Takeuchi Y: Limited uptake of foreign materials by resident macrophages in murine ovarian tissues. J Reprod Immunol 1999; 43:5566.
  • 51
    Hameed A, Fox W, Kurman RJ, Hruban RH, Podack ER: Perforin expression in human cell-mediated luteolysis. Int J Gynecol Pathol 1995; 14:151157.
  • 52
    Best CL, Pudney J, Welch W, Burger N, Hill JA: Localization and characterization of white blood cell populations within the human ovary throughout the menstrual cycle and menopause. Hum Reprod 1996; 11:790797.
  • 53
    Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Date F, Nagura H: Leukocytes in normal-cycling human ovaries: immunohistochemical distribution and characterization. Hum Reprod 1998;13:21862191.
  • 54
    Wang LJ, Pascoe V, Petrucco OM, Norman RJ: Distribution of leukocyte subpopulations in the human corpus luteum. Hum Reprod 1992; 7:197202.
  • 55
    Gaytán F, Morales C, García-Pardo L, Reymundo C, Bellido C, Sanchez-Crlado JE: Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum. Biol Reprod 1998; 59:417425.
  • 56
    Duncan WC, Rodger FE, Illingworth PJ: The human corpus luteum: reduction in macrophages during simulated maternal recognition of pregnancy. Hum Reprod 1998; 13:24352442.
  • 57
    Penny LA, Armstrong DG, Baxter G, Hogg C, Kindahl H, Bramley T, Watson ED, Webb R: Expression of monocyte chemoattractant protein-1 in the bovine corpus luteum around the time of natural luteolysis. Biol Reprod 1998; 59:14641469.
  • 58
    Kliem H, Berisha B, Meyer HHD, Schams D: Regulatory changes of apoptotic factors in the bovine corpus luteum after induced luteolysis. Mol Reprod Dev 2009; 76:220230.
  • 59
    Cavicchio VA, Pru JK, Davis BS, Davis JS, Rueda BR, Townson DH: Secretion of monocyte chemoattractant protein-1 by endothelial cells of the bovine corpus luteum: regulation by cytokines but not prostaglandin F2α. Endocrinology 2002; 143:35823589.
  • 60
    Tsai SJ, Juengel JL, Wiltbank MC: Hormonal regulation of monocyte chemoattractant protein-1 messenger ribonucleic acid expression in corpora lutea. Endocrinology 1997; 138:45174520.
  • 61
    Polec A, Tanbo T, Fedorcsak P: Cellular interaction regulates interleukin-8 secretion by granulosa-lutein cells and monocytes/macrophages. Am J Reprod Immunol 2009; 61:8594.
  • 62
    Lawler DF, Brazil TJ, Dagleish MP, Watson ED: Chemoattractant properties of conditioned medium from equine corpora lutea collected at various stages of the oestrous cycle. Equine Vet J 2002; 34:279282.
  • 63
    Petroff MG, Petroff BK, Pate JL: Expression of cytokine messenger ribonucleic acids in the bovine corpus luteum. Endocrinology 1999; 140:10181021.
  • 64
    Sakumoto R, Berisha B, Kawate N, Schams D, Okuda K: Tumor necrosis factor-α and its receptor in bovine corpus luteum throughout the estrous cycle. Biol Reprod 2000; 62:192199.
  • 65
    Shaw DW, Britt JH: Concentrations of tumor necrosis factor alpha and progesterone within the bovine corpus luteum sampled by continuous-flow microdialysis during luteolysis in vivo. Biol Reprod 1995; 53:847854.
  • 66
    Benyo DF, Pate JL: Tumor necrosis factor-alpha alters bovine luteal cell synthetic capacity and viability. Endocrinology 1992; 130:854860.
  • 67
    Cannon MJ, Pate JL: Role of major histocompatibility molecules in luteal function. Reprod Biol Endocrinol 2003; 1:93.
  • 68
    Skarzynski DJ, Bah MM, Deptula KKM, Woclawek-Potocka I, Korzekwa A, Shibaya M, Pilawski W, Okuda K: Roles of tumor necrosis factor-α of the estrous cycle in cattle: an in vivo study. Biol Reprod 2003; 69:19071913.
  • 69
    Korzekwa A, Murakami S, Woclawek-Potocka I, Bah MM, Okuda K, Skarzynski DJ: The influence of tumor necrosis factor α (TNF) on the secretory function of bovine corpus luteum: TNF and its receptors expression during the estrous cycle. Reprod Biol 2008; 8:245262.
  • 70
    Fairchild DL, Pate JL: Interferon-gamma induction of major histocompatibility complex antigens on cultured bovine luteal cells. Biol Reprod 1989; 40:453.
  • 71
    Fairchild DL, Pate JL: Modulation of bovine luteal cell synthetic capacity by interferon-gamma. Biol Reprod 1991; 44:357363.
  • 72
    Taniguchi H, Yokomizo Y, Okuda K: Fas-Fas ligand system mediates luteal cell death in bovine corpus luteum. Biol Reprod 2002; 66:754759.
  • 73
    Cannon MJ, Pate JL: Indoleamine 2,3-dioxygenase participates in the interferon-gamma-induced cell death process in cultured bovine luteal cells. Biol Reprod 2006; 74:552559.
  • 74
    Krakauer T, Oppenheim JJ: IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 1993; 150:12051211.
  • 75
    Petroff MG, Petroff BK, Pate JL: Mechanisms of cytokine-induced death of cultured bovine luteal cells. Reproduction 2001; 121:753760.
  • 76
    Al-Zi’abi MO, Bowolaksono A, Okuda K: Survival role of locally produced acetylcholine in the bovine corpus luteum. Biol Reprod 2009; 80:823832.
  • 77
    Rueda BR, Hendry IR, Hendry WJ III, Stormshak F, Slayden OD, Davis JS: Decreased progesterone levels and progesterone receptor antagonists promote apoptotic cell death in bovine luteal cells. Biol Reprod 2000; 62:269276.
  • 78
    Nothnick WB, Pate JL: Interleukin-1β is a potent stimulator of prostaglandin synthesis in bovine luteal cells. Biol Reprod 1990; 43:898.
  • 79
    Nishimura R, Bowolaksono A, Acosta TJ, Murakami S, Piotrowska K, Skarzynski DJ, Okuda K: Possible role of interleukin-1 in the regulation of bovine corpus luteum throughout the luteal phase. Biol Reprod 2004; 71:16881693.
  • 80
    Bove SE, Petroff MG, Nishibori M, Pate JL: Macrophage migration inhibitory factor in the bovine corpus luteum: characterization of steady-state messenger ribonucleic acid and immunohistochemical localization. Biol Reprod 2000; 62:879885.
  • 81
    Brunswig-Spickenheier B, Mukhopadhyay AK: Expression of osteopontin (OPN) mRNA in bovine ovarian follicles and corpora lutea. Reprod Domest Anim 2003; 38:175181.
  • 82
    Poole DH, Ndiaye K, Pate JL: Potential role of secreted phosphoprotein 1 in the bovine corpus luteum. World Congress on Reproductive Biology 2001; abstract no. 34.
  • 83
    Gangrade BK, Gotcher ED, Davis JS, May JV: The secretion of transforming growth factor-beta by bovine luteal cells in vitro. Mol Cell Endocrinol 1993; 93:117123.
  • 84
    Hou X, Arvisais EW, Jiang C, Chen D, Roy SK, Pate JL, Hansen TR, Rueda BR, Davis JS: Prostaglandin F2α stimulates the expression and secretion of transforming growth factor B1 via induction of the early growth response 1 gene (EGR1) in the bovine corpus luteum. Mol Endocrinol 2008; 22:403414.
  • 85
    Simón C, Frances A, Piquette G, Polan ML: Immunohistochemical localization of the interleukin-1 system in the mouse ovary during follicular growth, ovulation, and luteinization. Biol Reprod 1994; 50:449457.
  • 86
    Tsuji Y, Tamaoki TH, Hasegawa A, Kashiwamura S, Iemoto A, Ueda H, Muranaka J, Adachi S, Furuyama J, Okamura H, Koyama K: Expression of interleukin-18 and its receptor in mouse ovary. Am J Reprod Immunol 2001; 46:349357.
  • 87
    Hurwitz A, Finci-Yeheskel F, Yagel S, Shimonovitz S, Laufer N, Adashi EY, Mayer M: Interleukin-1β inhibits progesterone accumulation in rat corpora luteal cell cultures in a mechanism dissociated from its effects on nitric oxide and prostaglandin E accumulation. Mol Cell Endocrinol 1997; 133:4148.
  • 88
    Chen HF, Shew JY, Chao KH, Chang LJ, Ho HN, Yang YS: Luteinizing hormone up-regulates the expression of interleukin-1β mRNA in human granulose-luteal cells. Am J Reprod Immunol 2000; 43:125133.
  • 89
    Miceli F, Tropea A, Minici F, Navarra P, Lanzone A, Apa R: Interleukin-1β stimulates progesterone production by in vitro human luteal cells: evidence of a mediatory role of prostaglandins. J Clin Endocrinol Metab 2003; 88:26902694.
  • 90
    Castro A, Castro O, Troncoso JL, Kohen P, Simón C, Vega M, Devoto L: Luteal leukocytes are modulators of the steroidogenic process of human mid-luteal cells. Hum Reprod 1998; 13:15841589.
  • 91
    Kohen P, Castro A, Caballero-Campo P, Castro O, Vega M, Makrigiannakis A, Simon C, Carvallo P, Devoto L: Interleukin-1β (IL-1β) is a modulator of human luteal cell steroidogenesis: localization of the IL type I system in the corpus luteum. J Clin Endocrinol Metab 1999; 84:42394245.
  • 92
    Jo T, Terada N, Takauchi Y, Saji F, Nishizawa Y, Tanaka S, Kosaka H: Cytotoxic actions of cytokines on cultured mouse luteal cells are independent of nitric oxide. J Steroid Biochem Mol Biol 1995; 55:291296.
  • 93
    Jo T, Tomiyama T, Ohashi K, Saji F, Tanizawa O, Ozaki M, Yamamoto R, Yamamoto T, Nishizawa Y, Terada N: Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma. Anat Rec 1995;241:7076.
  • 94
    Kuranaga E, Kanuka H, Bannai M, Suzuki M, Nishihara M, Takahashi M: Fas/Fas ligand system in prolactin-induced apoptosis in rat corpus luteum: possible role of luteal immune cells. Biochem Biophys Res Commun 1999; 260:167173.
  • 95
    Peluffo MC, Young KA, Hennebold JD, Stouffer RL: Expression and regulation of tumor necrosis factor (TNF) and TNF-receptor family members in the macaque corpus luteum during the menstrual cycle. Mol Reprod Dev 2009; 76:367378.
  • 96
    Brannstrom M, Friden BE, Jasper M, Norman RJ: Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum. Eur J Obstet Gynecol Reprod Biol 1999;83:213217.
  • 97
    Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, Puder M, Davis JS, Rueda BR: Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci USA 2008; 105:76707675.
  • 98
    Neuvians TP, Schams D, Berisha B, Pfaffl MW: Involvement of pro-inflammatory cytokines, mediators of inflammation, and basic fibroblast growth factor in prostaglandin F2α-induced luteolysis in bovine corpus luteum. Biol Reprod 2004;70:473480.
  • 99
    Friedman A, Weiss S, Levy N, Meidan R: Role of tumor necrosis factor α and its type I receptor in luteal regression: induction of programmed cell death in bovine corpus luteum-derived endothelial cells. Biol Reprod 2000; 63:19051912.
  • 100
    Lehmann I, Brylla E, Sittig D, Spanel-Borowski K, Aust G: Microvascular endothelial cells differ in their basal and tumour necrosis factor-α-regulated expression of adhesion molecules and cytokines. J Vasc Res 2000; 37:408416.
  • 101
    Liptak AR, Sullivan BT, Henkes LE, Wijayagunawardane MPB, Miyamoto A, Davis JS, Rueda BR, Townson DH: Cooperative expression of monocyte chemoattractant protein 1 within the bovine corpus luteum: evidence of immune cell-endothelial cell interactions in a coculture system. Biol Reprod 2005; 72:11691176.
  • 102
    Kisliouk T, Friedman A, Klipper E, Zhou QY, Schams D, Alfaidy N, Meidan R: Expression pattern of prokinectin 1 and its receptors in bovine ovaries during the estrous cycle: involvement in corpus luteum regression and follicular atresia. Biol Reprod 2007; 76:749758.
  • 103
    Cannon MJ, Davis JS, Pate JL: Presence and regulation of messenger ribonucleic acids encoding components of the class II major histocompatibility complex-associated antigen processing pathway in the bovine corpus luteum. Reproduction 2006; 131:689698.
  • 104
    Cannon MJ, Davis JS, Pate JL: Expression of costimulatory molecules in the bovine corpus luteum. Reprod Biol Endocrinol 2007; 5:5.
  • 105
    Benyo DF, Haibel GK, Laufman HB, Pate JL: Expression of major histocompatibility complex antigens on the bovine corpus luteum during the estrous cycle, luteolysis, and early pregnancy. Biol Reprod 1991; 45:229.
  • 106
    Petroff MG, Coggeshall KM, Jones LS, Pate JL: Bovine luteal cells elicit major histocompatibility complex class II-dependent T cell proliferation. Biol Reprod 1997; 57:887893.
  • 107
    Hayday AC: [gamma][delta] cells: a right time and a right place for a conserved way of protection. Annu Rev Immunol 2000; 18:9751026.
  • 108
    Itohara S, Farr AG, Lafaille JJ, Bonneville M, Takagaki Y, Haas W, Tonegawa S: Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature 1990; 343:754757.
  • 109
    Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 1993; 11:637685.
  • 110
    Heyborne KD, Cranfill RL, Carding SR, Born WK, O’Brien RL: Characterization of gamma delta T lymphocytes at the maternal-fetal interface. J Immunol 1992; 149:28722878.
  • 111
    Polgar B, Barakonyi A, Xynos I, Szekeres-Bartho J: The role of gamma/delta T cell receptor positive cells in pregnancy. Am J Reprod Immunol 1999; 41:239244.
  • 112
    Bukovsky A, Caudle MR, Keenan JA: Dominant role of monocytes in control of tissue function and aging. Med Hypotheses 2000; 55:337347.